Jonathan Siegrist, PhD, is a senior biotechnology and diagnostics executive with 15+ years of experience leading global research and development. As an officer at QuidelOrtho, he oversees global R&D strategy, driving innovation across molecular diagnostics, microfluidic platforms, and integrated diagnostic solutions. Previously, he served as Chief Technology Officer and Head of Assay Research and Development at Cepheid, where he contributed to the development and commercialization of molecular diagnostic assays. He is recognized for leading multidisciplinary teams and translating scientific innovation into scalable products. Dr. Siegrist holds a PhD and M.S. in Biomedical Engineering from the University of California, Irvine, and a B.S. in Electrical Engineering from the University of California, Los Angeles.